Tejas Patel, MD, FACP, FASN
Patel T. Canagliflozin reduced kidney failure and CV events at 2.6 years in type 2 diabetes with chronic kidney disease. Ann Intern Med. 2019;171:JC15. doi: 10.7326/ACPJ201908200-015
Download citation file:
Published: Ann Intern Med. 2019;171(4):JC15.
Cardiology, Chronic Kidney Disease, Coronary Risk Factors, Diabetes, Diabetic Nephropathy.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use